💊Small Molecule Drugs
Traditional chemically synthesized drugs that can be taken orally. Includes blockbusters like statins, antivirals, and kinase inhibitors.
Market Cap$4.4T
1D+0.23%
Companies2,113
Public Cos211
SECTOR MARKET CAP
$4.4T+326.8%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $809.7B | LLY |
| 2 |  | United States | $362.6B | ABBV |
| 3 |  | Switzerland | $325.4B | ROG.SW |
| 4 |  | United Kingdom | $284.6B | AZN |
| 5 |  | United States | $282.3B | MRK |
| 6 |  | Switzerland | $278.6B | NVS |
| 7 |  | United States | $187.5B | AMGN |
| 8 |  | United States | $170.3B | GILD |
| 9 |  | United States | $153.4B | PFE |
| 10 |  | United States | $117.1B | BMY |
| 11 |  | United States | $115.3B | VRTX |
| 12 |  | France | $107.3B | SNY |
| 13 |  | United Kingdom | $103.7B | GSK |
| 14 |  | Japan | $56.3B | TAK |
| 15 |  | China | $51.1B | 600276.SS |
| 16 |  | India | $45.4B | SUNPHARMA.NS |
| 17 |  | Germany | $43.5B | BAYN.DE |
| 18 |  | Japan | $35.5B | 4578.T |
| 19 |  | Israel | $33.5B | TEVA |
| 20 |  | Japan | $33.4B | 4568.T |